32 results about "Treatment duration" patented technology

Dialysis device for performing peritoneal dialysis with at least one control unit, with at least one input unit for inputting one or more values, and with at least one processor, wherein the processor is designed to perform a method for estimating the treatment duration of a peritoneal dialysis treatment, wherein the estimation of the treatment duration is based on an ideal treatment duration, wherein the ideal treatment duration is increased by one or more delay values, characterized in that the delay values ​​depend on one or more patient-specific parameters.where a patient-specific parameter is catheter performance and the catheter performance is taken into account when estimating the infusion time and / or when estimating the outflow time and / or when estimating the duration of the last infusion, and the catheter performance, and in particular an absolute or relative increase thereof, is editable by a user.

The utility model provides a stoma enema instrument, which belongs to the technical field of medical instruments, and comprises an outer fixing sleeve, a protective component, an inner fixing sleeve and a fixing component, the outer wall of the outer fixing sleeve is fixedly connected with uniformly distributed sliding frames, and the protective component comprises a contact sleeve slidably connected to the outer walls of the sliding frames. The outer wall of the contact sleeve is fixedly connected with telescopic rods which are evenly distributed, the telescopic rods are fixedly connected with the outer fixing sleeve, and the outer walls of the telescopic rods are sleeved with strong springs. According to the drainage tube fixing device, the position can be freely adjusted through the arranged clamping plates, drainage tubes with different thicknesses can be clamped and fixed, installation and fixing of the drainage tubes with different tube diameters can be easily and rapidly completed without frequently replacing equipment or using additional auxiliary tools, operation convenience and efficiency are greatly improved, and the drainage tube fixing device is convenient to use and high in practicability. An enema system can be conveniently and rapidly built in an emergency, precious treatment time is won for a patient, and the medical cost is reduced.

The invention provides an integral femoral artery cannula plugging device after ECMO machine removal, which comprises a main tube, a connecting mechanism, a drainage tube, a drainage tube, a drainage tube and a drainage tube, and is characterized in that the main tube is movably mounted in a femoral artery cannula through the connecting mechanism; the connecting mechanism comprises a bag body and a connecting hose, and the bag body is installed outside the main pipe; one end of the connecting hose is connected with the bag body, a valve is arranged at the other end of the connecting hose, expansion or contraction of the bag body is controlled by injecting or releasing a medium into the bag body, and plugging or opening of the femoral artery cannula is achieved. Blocking and opening of the cannula are achieved through expansion / contraction of the bag body, complexity of cannula treatment after traditional machine removal is avoided, the cannula can be directly used when the cannula is used on a machine again, and key treatment time is saved; the double-cavity structure can achieve tube washing and tube sealing respectively, and the risk of thrombus formation is effectively reduced; the probability that external pollutants enter can be reduced through bag body plugging and cock auxiliary sealing, and the infection risk is reduced.

An apparatus for locating and venting pathogen cells in blood. A cassette has a plurality of thin holding chambers that are filled with blood drawn from a patient. A light source illuminates each of the holding chambers and passes light to an underlying sensor array such that the cells in the blood produce shadow images of the cells in the sensor array. A processor performs pattern recognition to identify and locate the pathogen cells by use of an image library. After the pathogen cells are located, a pump is operated to move the identified cells to a processing zone. When each identified cell reaches the processing zone, a control voltage is generated to open a valve to vent the identified pathogen cells. The pump refills the cassette holding chambers, returns the processed blood to the patient, and the procedure is repeated for a treatment time period.

The invention belongs to the technical field of medical data processing, and provides a multimodal fusion-based liver cancer longitudinal relapse prediction and treatment effect evaluation system, which comprises a data set construction module, which is used for forming a longitudinal queue data set by using longitudinal queue data samples of a plurality of patients, and setting a relapse time label for each longitudinal queue data sample; the training module is used for training a recurrence network by utilizing the longitudinal queue data set to obtain a recurrence model; the recurrence prediction module inputs the to-be-predicted longitudinal queue data of the patient into the recurrence model to obtain a prediction result of each treatment time point, and the prediction result comprises the recurrence probability of more than one future time period; the curative effect evaluation module is used for acquiring simulation longitudinal queue data corresponding to different treatment modes selected by the to-be-evaluated patient at the current relapse time point; and inputting the simulated longitudinal queue data into the recurrence model to obtain a prediction result of each treatment time point. According to the method, the accuracy and generalization of the recurrence model are improved, and doctors are accurately and efficiently assisted in selecting treatment modes.

The invention discloses an intelligent reservation number calling system and a method thereof, and belongs to the technical field of medical information. The system comprises a data acquisition module, an intelligent estimation module, a resource collaborative scheduling module and a patient service module. By collecting static and dynamic treatment data of a patient, personalized dynamic estimation of the treatment duration is realized; generating an optimized daily scheduling plan based on multi-dimensional constraints such as mold type collaboration, equipment load and human state; and the queuing information and the equipment state are pushed to the patient in real time. According to the invention, the problems of uncertain treatment duration, non-cooperative resource scheduling and non-transparent information of the radiotherapy center are solved, and comprehensive improvement of accurate reservation, efficient scheduling and patient experience is realized.

Devices, systems, and methods for localized delivery of a chemotherapy, hormonal therapy, or targeted drug / biologic therapy to a target tissue area of an internal body organ of a patient. Computer systems may be used for planning and navigation in super selective drug delivery via a tracheobronchial airway. A catheter may be used to form a sealed treatment chamber in a natural lumen extending through the target tissue area. Air is purged from the chamber, which is then filled with a liquid drug solution for an adequate treatment session time, solution volume and drug concentration to saturate the target tissue area, thereby providing the treatment. The liquid drug solution may be circulated or recirculated through the chamber or maintained stationary therewithin to saturate the target tissue area. The chamber is evacuated at the end of the treatment session.

To provide a suitable method and system for consistent, prepareable, and safe cryospray treatment of airway tissue. [Solution] A method and system for automated and semi-automated, predictable, consistent, safe, effective, lumen-specific, and patient-specific cryospray treatment of airway tissue, wherein, following input of patient information and treatment location information by the user into the system, the treatment duration is automatically set by the system, and the treatment spray is automatically stopped by the system when the automatically selected treatment duration is achieved as determined by the system.

The invention discloses a physiotherapy equipment tail end contact medium identification method based on impact rheological characteristics. Compared with the prior art, the method has the advantages that identification accuracy and cheating prevention are improved, the defect that treatment time is also calculated when a traditional current method is pressed on a table is overcome, and the algorithm can be confirmed to be effective only when the method is really pressed on biological tissue with viscoelasticity; hardware cost is reduced, a pure software algorithm is adopted, a pressure sensor or a distance sensor does not need to be added, and large-scale mass production is facilitated; and safety protection: abnormal oscillation on bones can be recognized in milliseconds, and bone contusion of old people or rehabilitation patients is prevented.

The present application relates to the field of medicine, and discloses an integrated emergency stroke unit having regions. The integrated emergency stroke unit having regions comprises an information interaction area, an imaging examination area, and a thrombolysis treatment area. The information interaction area is provided with a doctor workstation, a comprehensive information monitoring display, and a process-support AI assistant. The imaging examination area is provided with a detection device, a first television display screen, a low-field movable magnetic resonance imager, and an AI-assisted decision-making system. The process-support AI assistant performs automated consultation and assists in nervous system scale scoring by means of voice interaction or touch screen input interaction, and also provides retrieval support for a real-time knowledge base and clinical guidelines. The AI-assisted decision-making system assists in decision-making on the basis of an automated consultation result, a scale scoring result, a detection result, and a head and neck magnetic resonance imaging result, generates a treatment plan, and displays the treatment plan. According to the present application, all diagnosis and treatment activities involved upon the arrival of a patient suffering from acute ischemic stroke at a hospital are integrated into a single space, which can significantly shorten diagnosis and treatment time.

The present application relates to the technical fields of ankle treatment, and specifically discloses a physiotherapy device for preventing and treating ankle injury, which comprises an ankle guard cover, two sides of the ankle guard cover are provided with mounting covers, a microwave treatment assembly is arranged inside the mounting cover, the microwave treatment assembly comprises a treatment head one arranged at the center of the mounting cover, an outer ring of the treatment head one is provided with a treatment ring one, a surface of the treatment ring one is connected with a treatment ring two through a connecting plate one, and an outer ring of the treatment ring one is provided with a treatment head two, a connecting assembly one and a driving assembly, the connecting assembly one is arranged at the side of the microwave treatment assembly, the driving assembly is arranged at the end face of the connecting assembly one, the connecting assembly one is moved through the driving assembly, and the swelling degree of the ankle part of a patient is monitored through the connecting assembly one; the most suitable microwave power and treatment time can be provided in real time according to the swelling degree of the ankle, treatment is more suitable for the changes of the patient's condition, and better treatment effect is achieved.

The present application belongs to the technical field of medical data processing, and provides a liver cancer longitudinal recurrence prediction and treatment efficacy evaluation system based on multi-modal fusion, comprising: a data set construction module, which uses multiple patient longitudinal cohort data samples to form a longitudinal cohort data set, and sets a recurrence time label for each longitudinal cohort data sample; a training module, which trains a recurrence network using the longitudinal cohort data set to obtain a recurrence model; a recurrence prediction module, which inputs the patient's to-be-predicted longitudinal cohort data into the recurrence model to obtain prediction results at each treatment time point, the prediction results including the recurrence probability of more than one future time period; and an efficacy evaluation module, which obtains simulated longitudinal cohort data corresponding to different treatment methods at the current recurrence time point of the patient to be evaluated; and inputs the simulated longitudinal cohort data into the recurrence model to obtain prediction results at each treatment time point. The present application improves the accuracy and generalizability of the recurrence model, and accurately and efficiently assists doctors in selecting treatment methods.

The utility model relates to the technical field of diabetic foot treatment, and particularly discloses a diabetic foot debridement device which comprises a box body, a foot placing table is arranged in the box body, the upper end face of the foot placing table is fixedly connected with a plurality of evenly-distributed toe separation supporting blocks, and the upper end of the interior of the box body is slidably connected with a movable plate. A first cavity and a second cavity which are distributed up and down are formed in the movable plate, a plurality of water spray nozzles which are uniformly distributed and communicate with the first cavity are fixedly connected to the lower end face of the movable plate, the air heater conveys hot air into the second cavity through a first pipeline, and then the hot air is sprayed out through the multiple air spray nozzles; water stains remaining on the outer wall of the foot are removed through hot air, then the treated foot is bound, then the water stains remaining on the foot are rapidly removed, the treatment time is effectively shortened, the foot does not need to be exposed in air for a long time, the wound surface is prevented from being polluted by environmental microorganisms, and the condition of a patient is prevented from being aggravated due to secondary infection.

The invention relates to the technical field of multi-modal magnetic resonance detection, and discloses a cerebral arterial thrombosis multi-modal magnetic resonance image difference detection method, which comprises the following steps: acquiring a multi-modal magnetic resonance image, forming an image set, forming difference data, acquiring a difference database, acquiring life data of a target patient, forming disease analysis data, and forming an evaluation result. According to the cerebral arterial thrombosis multi-mode magnetic resonance image difference detection method, difference data are automatically judged, genetic disease history, past medical history, dietary habits and sleep habits of a patient are automatically obtained, corresponding possible diseases of the patient are judged, each possible disease of the patient is automatically evaluated, and a detection evaluation report is generated. According to the method, the condition of missed diagnosis is avoided, the condition of misjudgment caused by the fact that living habits of the patient and data such as past medical history cannot be combined is avoided, the waiting and treatment time of the patient is shortened, and the doctor-patient contradiction caused by many examination items and high examination cost is reduced.

An information display and control system that enables a fast and easy understanding and management of the status of the patient's dialysis is disclosed. Also disclosed is an information display and control system that enables a fast and easy understanding and management of the status of the patient's cardiovascular and ventilation systems. The system can control management of a patient's dialysis, as well as administration and management of a patient's medication and fluids. The display is organized by goals related to management of patient's dialysis machine, blood flow, dialyzer flow, and patient's body weight. The display is also organized by goals related to management of patient's cardiovascular system, ventilation system, and medications and fluids administration and management. Such goals include urea reduction rate, urea reduction ratio, fractional urea clearance, total urea reduction, dialysis treatment duration, hemodynamics, oxygenation, CO2 removal, medication status, and fluids status.

Systems and methods for monitoring and managing neurological diseases and conditions are disclosed herein. In some embodiments, a method for monitoring a patient having a neurological disease or condition includes receiving, from one or more patient monitoring devices, first patient data for a baseline time period. The method can include determining, based on the first patient data, first seizure data and first side effect data during the baseline time period. The method can further include receiving, from the one or more patient monitoring devices, second patient data for a treatment time period, and determining, based on the second patient data, second seizure data and second side effect data during the treatment time period. The method can also include generating a personalized dose-response profile for the patient based on the first and second seizure data and the first and second side effect data.

The application relates to the field of biological medicine, and particularly discloses a fusion protein and application thereof. The fusion protein is composed of a polypeptide and six histidines, the polypeptide has sequence consistency of at least 9 / 10, 14 / 15 or 29 / 30 with the amino acid sequence shown in SEQ ID NO:1, and the six histidines are located at the C-terminal of the polypeptide. The fusion protein designed in the application is derived from a human body protein, the metabolic product is an amino acid, and therefore the safety is better than that of other therapeutic drugs. Moreover, the fusion protein can significantly reduce the infarction volume of the brain of a tMCAO model mouse, has a significant treatment on ischemic stroke, and has a longer treatment time window than that of an existing thrombolytic drug. Compared with the existing ischemic stroke treatment drug, the human sTREM2-6His fusion protein has a brand-new treatment mechanism and target.

The invention discloses a breast cancer postoperative automatic rehabilitation assisting method and related equipment. The method comprises the steps that a near-end physiological signal of a target patient is obtained, the near-end physiological signal is used for representing the liquid load or compliance state of near-end tissue, and the near-end tissue comprises at least one of anterior axillary line, subclavian, scapular region and chest wall; calculating a near-end fullness index of the target patient based on the near-end physiological signal; and under the condition that the near-end filling degree index does not reach a preset release threshold value, a pressurizing assembly is controlled to preferentially maintain or prolong the maintaining and emptying time interval of the near-end cavity, and starting of the far-end cavity is limited. The problem that in current clinical practice, part of medical institutions adopt a one-cut air pressure treatment scheme such as a fixed pressure gradient, a single inflation mode or a constant treatment duration, and the standardized operation neglects pathological differences among individual patients although the standardized operation is convenient to execute can be solved.

Described herein are compositions and methods for treating ischemic injury in a subject comprising administering a therapeutically effective amount of an acellular amniotic fluid (acAF) to an ischemic injury situs within a therapeutic time window.

The application discloses an intestinal cancer immune response graph neural network prediction system, medium and equipment, through collecting pathological image information, immune detection information and basic clinical information, using a deep convolution network to extract a tissue spatial distribution feature map, combining an immune marker expression characteristic matrix to construct a graph neural network model, adopting a graph attention mechanism to model spatial interaction characteristics of a tumor microenvironment, finally predicting a treatment response probability, an optimal treatment time and an adverse reaction risk through a multi-task learning framework, and outputting a clinical decision report containing a predicted response curve, a risk early warning threshold and a treatment time window suggestion. Through multi-modal data fusion and spatial interaction modeling, the application realizes accurate prediction of the intestinal cancer immunotherapy response, and provides a more comprehensive reference basis for clinical decision-making.

An information display and control system that enables a fast and easy understanding and management of the status of the patient's dialysis is disclosed. Also disclosed is an information display and control system that enables a fast and easy understanding and management of the status of the patient's cardiovascular and ventilation systems. The system can control management of a patient's dialysis, as well as administration and management of a patient's medication and fluids. The display is organized by goals related to management of patient's dialysis machine, blood flow, dialyzer flow, and patient's body weight. The display is also organized by goals related to management of patient's cardiovascular system, ventilation system, and medications and fluids administration and management. Such goals include urea reduction rate, urea reduction ratio, fractional urea clearance, total urea reduction, dialysis treatment duration, hemodynamics, oxygenation, CO2 removal, medication status, and fluids status.

The invention discloses an ultrasonic main machine head and an ultrasonic therapeutic apparatus. The ultrasonic main machine head comprises an annular bag, an annular shell, an ultrasonic patch, a sliding block and a driving piece. The ring bag is used for sleeving an injured limb of a patient, and an inner cavity of the ring bag is used for feeding or discharging a coupling agent; the ring shell is sleeved outside the ring bag; the sliding block is slidably arranged on the annular shell, and one face of the sliding block is right opposite to the peripheral face of the annular bag. The ultrasonic patch is attached to one surface, facing the annular bag, of the sliding block and is in contact with the peripheral surface of the annular bag; and the driving piece is arranged on the annular shell and connected with the sliding block, and the driving piece is used for driving the sliding block to do circular motion in the circumferential direction of the annular shell. Thus, automatic alternation of the treatment area is achieved through mechanical movement, the skin surface temperature is effectively controlled to be within the safe range all the time on the premise that the total treatment dosage is not reduced, and therefore the single continuous treatment time is prolonged, the treatment efficiency is improved, and the use safety and comfort of a patient are improved.

This invention provides a photocurable hydrogel, its preparation method, and its applications. The photocurable hydrogel comprises 45-55 parts of gel complex 1, 45-55 parts of gel complex 2, 0.01-0.5 parts of photoinitiator, and 1-10 parts of natural plant extract. The hydrogel of this invention exhibits good biocompatibility and biodegradability. The photocuring process is convenient, and it can significantly reduce the inflammation level in tissue repair after pterygium excision, improve the repair rate, shorten treatment time, avoid secondary surgery, reduce patient suffering and medical risks, and has a simple and low-cost preparation process, facilitating industrial production and large-scale application.

This disclosure provides a method and related apparatus for determining the efficacy of anlotinib, involving artificial intelligence technologies such as efficacy prediction, machine learning, deep learning, and pharmacokinetic models. The method includes: acquiring the patient's anlotinib dosage, treatment duration, weight, and blood drug concentration observation time points; using the dosage, treatment duration, weight, and blood drug concentration observation time points as input data for a pre-set blood drug concentration prediction model to obtain the output blood drug concentration parameter; responding to a patient's efficacy prediction function selection command, acquiring the patient's actual age; and using the blood drug concentration parameter and actual age as input data for the pre-set efficacy prediction model to obtain the output cancer progression probability. Applying this method can improve the accuracy of determining the actual efficacy of anlotinib in individual patients based on individual differences, thus facilitating precision medication.

This invention discloses an artificial intelligence-based individualized parameter optimization system for transcranial magnetic stimulation (TMS) therapy, belonging to the technical field of TMS optimization systems. This AI-based individualized parameter optimization system for TMS therapy includes a data acquisition and preprocessing module, a feature extraction module, a treatment parameter prediction module, and a treatment effect evaluation module. The data acquisition module is used to collect the patient's brain function data in real time; the feature extraction module is used to extract features from the preprocessed brain function data and clinical data; the treatment parameter prediction module is used to determine a treatment plan suitable for the patient's current condition based on the predicted TMS treatment parameters; and the treatment effect evaluation module is used to continuously monitor the patient's brain function data during treatment. This system solves the problems of traditional TMS therapy, where parameter settings rely on experience and generalized guidelines, lack individualized optimization, and require parameter adjustments, leading to inaccurate treatment effects and long treatment times.

The utility model discloses a portable integrated soft cystoscope which comprises a handle body and a butt joint block fixedly installed at the upper end of the handle body, an installation piece is installed at the upper end of the butt joint block in a clamped mode, a display screen assembly is fixedly installed on the outer side of the installation piece, and a connecting hose is installed at the lower end of the handle body in a threaded mode. A probe is fixedly installed at the end, away from the handle body, of the connecting hose. According to the portable integrated soft cystoscope, the design of the portable integrated soft cystoscope enables most of patients in regions to enjoy the convenience of outpatient catheterization, so that for the patients, the complicated hospital entering and exiting processes are avoided, the medical treatment efficiency is improved, and for hospitals, the diagnosis and treatment rate of outpatient and emergency treatment is also improved; meanwhile, the national medical insurance expenditure is relatively reduced, the urethral catheter can also be used for urethral foreign body taking in emergency treatment, urethral injury exploration treatment in emergency treatment and auxiliary catheterization during difficult catheterization in emergency, and the treatment time is effectively shortened.

A method for treating a patient for anxiety, depression, and insomnia. The method includes generating a stimulation conveyed to the patient for a treatment duration current via generating a carrier waveform being an alternating current having a duty cycle ratio and a current amplitude ratio being selected such that each respective integration of the current amplitude between successive time instances at which the carrier waveform alternates polarity is substantially equivalent. The method further includes generating a stimulation current from the carrier waveform via amplitude modulating the carrier waveform. The extremes of the stimulation current defining a stimulation current envelope defining first and second series of pulses. The first series of pulses occurring at a first frequency that does not substantially vary for the entire treatment duration, and the second series of pulses occurring at a second frequency that varies during the treatment duration.

To provide a catheter for venous thrombus treatment which shortens the treatment time of a lesion part.SOLUTION: A catheter 10 for venous thrombus treatment treats a lesion 16 having an organized thrombus 20 of a vein 14 in a living body 12. A catheter for venous thrombosis treatment includes a first catheter 24, and a second catheter 26 movably inserted into a first lumen 241 of the first catheter and having an outer diameter D2 smaller than an outer diameter D of organized thrombi. The second catheter is projectable distally from the distal end 321 of the first catheter.SELECTED DRAWING: Figure 1

The present invention relates to the field of biopharmaceutical technology, and in particular, to use of a nitroimidazole derivative or a pharmaceutical combination in the preparation of a medicament against drug-sensitive tuberculosis. Animal studies, phase I and phase II clinical trials, and the optimization of dosage and route of administration have demonstrated that the nitroimidazole derivative has no significant drug accumulation, no significant reproductive toxicity, no significant cardiotoxicity, and no QT prolongation effects. Compared with existing drugs such as delamanid, the nitroimidazole derivative has shorter treatment time, more significant therapeutic effects, and higher safety. Especially in pulmonary images, the cavities in patients are significantly reduced, or the lesions are significantly absorbed, suggesting that the nitroimidazole derivative is promising as a novel drug for preventing and treating drug-sensitive tuberculosis.

The invention relates to a periodic Cushing syndrome screening method. A marker of the method is annexin A1. Compared with an existing periodic Cushing syndrome identification method, the method has the advantages that only further examination and treatment measures need to be taken when cortisol exceeds normal again, so that the treatment time of a patient is remarkably shortened, the life quality of the patient is remarkably improved, medical resources are remarkably saved, missed diagnosis and misdiagnosis of the periodic Cushing syndrome are reduced, and the method is suitable for popularization and application. And the method has remarkable economic and social benefits.